Process and system for obtaining botulinum neurotoxin | Patent Publication Number 20220228136

US 20220228136 A1
Patent NumberUS 11518986 B2
Application Number17694932
Filled DateMar 15, 2022
Priority DateJul 13, 2009
Publication DateJul 21, 2022
Original AssigneeAbbvie Inc.
Current AssigneeAllergan
Inventor/ApplicantsWajdie M. Ahmad
Jennifer L. Ton
Hemant A. Patel
Ronald C. Bates
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.